Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aqua Bio Technology ASAOSTO:ABTO 37 3-Year EBITDA Growth Rate is 60.10% as of Dec. 2025, which is 124% above its 10-year median of 26.80. GuruFocus rates OSTO:ABTO with a GF Score™ of 37/100 and a GF Value™ of kr4.08. The stock has 5 warning signs investors should review. Among 1,129 Biotechnology companies, Aqua Bio Technology ASA ranks better than 90.17% on this metric.
During the past 12 months, Aqua Bio Technology ASA's average EBITDA Per Share Growth Rate was -104.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 60.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Aqua Bio Technology ASA was 60.10% per year. The lowest was -5.30% per year. And the median was 26.80% per year.
Aqua Bio Technology ASA (OSTO:ABTO) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Aqua Bio Technology ASA 3-Year EBITDA Growth Rate Related Terms
OSTO:ABTO vs VRTX, REGN, RVMD: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, Aqua Bio Technology ASA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aqua Bio Technology ASA 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Aqua Bio Technology ASA's 3-Year EBITDA Growth Rate falls into.
Aqua Bio Technology ASA 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 60.10% mean?
Aqua Bio Technology ASA (OSTO:ABTO) has a 3-Year EBITDA Growth Rate of 60.10% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Aqua Bio Technology ASA and its competitors. This is 124% above median its historical median of 26.80. According to the industry distribution chart, Aqua Bio Technology ASA ranks #111 out of 1129 companies in the Biotechnology industry, placing it in the top 9.8%.
Is Aqua Bio Technology ASA's 3-Year EBITDA Growth Rate too high?
Aqua Bio Technology ASA's current 3-Year EBITDA Growth Rate of 60.10% is 124% above median its 10-year median of 26.80. The Biotechnology industry median 3-Year EBITDA Growth Rate is 14.90. Aqua Bio Technology ASA's value of 60.10% is 303.4% above this industry median. Based on the distribution chart, Aqua Bio Technology ASA ranks #111 out of 1129 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Aqua Bio Technology ASA has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Aqua Bio Technology ASA's 3-Year EBITDA Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aqua Bio Technology ASA ranks #111 out of 1129 companies for 3-Year EBITDA Growth Rate. This places Aqua Bio Technology ASA in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 14.90. Aqua Bio Technology ASA's value of 60.10% is 303.4% above this benchmark. While the company's 10-year median is 26.80 vs. the industry median of 14.90, Aqua Bio Technology ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.90, based on 1,129 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aqua Bio Technology ASA's current 3-Year EBITDA Growth Rate of 60.10% is 303.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Aqua Bio Technology ASA and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aqua Bio Technology ASA's current 3-Year EBITDA Growth Rate is 60.10%, which is 124% above median its own 10-year median of 26.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aqua Bio Technology ASA stock overvalued right now?
Aqua Bio Technology ASA (OSTO:ABTO) has a current 3-Year EBITDA Growth Rate of 60.10%. The stock's GF Value™ is kr4.08, compared to a current price of kr6.82 — trading 67.2% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 60.10%, which is 124% above median its 10-year median of 26.80 and 303.4% above the Biotechnology industry median of 14.90. Aqua Bio Technology ASA's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Aqua Bio Technology ASA (OSTO:ABTO), the current 3-Year EBITDA Growth Rate is 60.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aqua Bio Technology ASA (OSTO:ABTO) Overvalued in 2026?
Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued.
The current stock price of kr6.82 is trading 67.2% above its estimated GF Value™ of kr4.08.
Key valuation signals for OSTO:ABTO:
3-Year EBITDA Growth Rate: 60.10% (124% above median its 10-year median of 26.80)
GF Value™: kr4.08 vs. price of kr6.82 (67.2% above fair value)
Industry Position: 303.4% above the Biotechnology median (#111 of 1129)
No single metric tells the full story. See the OSTO:ABTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
37GF Score
Get the complete analysis for OSTO:ABTO
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ABTO has been successfully added to your 
